SCHEMBL16166749

SCHEMBL16166749

O=C(Nc1ccc(C(F)(F)F)cc1)c1cc([N+](=O)[O-])ccc1Br

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 4/20 0.61
▸ TMPRSS4 Q9NRS4 2/20 0.61
▸ SMN1; SMN2 Q16637 4/20 0.60
▸ ABCG2 Q9UNQ0 1/20 0.60
▸ MAPT P10636 6/20 0.51
▸ CYP3A4 P08684 2/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ PPARG P37231 2/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.51
▸ XBP1 P17861 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ PPARA Q07869 1/20 0.51
▸ KMT2A Q03164 5/20 0.50
▸ MEN1 O00255 4/20 0.50
▸ PKM P14618 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16166595 0.87 MAOB (0.64) P2RX1TMPRSS4MAPTKMT2AMEN1
SCHEMBL30868357 0.86 P2RX1 (0.62) P2RX1TMPRSS4SMN1; SMN2ABCG2MAPT
SCHEMBL18146485 0.86 MAPT (0.56) P2RX1TMPRSS4SMN1; SMN2MAPTCYP3A4
SCHEMBL18146911 0.85 SMN1; SMN2 (0.71) P2RX1TMPRSS4SMN1; SMN2ABCG2MAPT
SCHEMBL16166867 0.83 P2RX1 (0.51) P2RX1TMPRSS4SMN1; SMN2ABCG2MAPT
SCHEMBL5079427 0.83 MAPT (0.71) SMN1; SMN2MAPTCYP3A4MAPK1PPARG
SCHEMBL13885092 0.80 SMN1; SMN2 (0.68) P2RX1TMPRSS4SMN1; SMN2MAPTNPSR1
SCHEMBL11972898 0.80 RAB9A (0.68) ABCG2MAPTMAPK1KMT2AMEN1
SCHEMBL13428706 0.80 RAB9A (0.68) ABCG2MAPTMAPK1KMT2AMEN1
SCHEMBL28330879 0.78 MEN1 (0.68) SMN1; SMN2ABCG2MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014167444-A1 SUBSTITUTED BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2014-10-16 — — WO disclosed
WO-2014167444-A1 SUBSTITUTED BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2014-10-16 — — WO disclosed
Send feedback